Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Seegene unveils solutions to popularize molecular diagnostics at 2023 AACC 2023-08-01 00:00
Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together 2023-07-31 20:30
WuXi AppTec Announced Strong Results of the Second Quarter and First Half of 2023, on Top of an Exceptionally Strong Year in 2022 2023-07-31 18:02
Biosion Announces Phase II Study Start for Anti-TSLP mAb BSI-045B in Atopic Dermatitis (ADAMANT) 2023-07-31 17:05
GLOBAL SARCOMA THERAPY NOW LISTED ON PHARMACEUTICAL BENEFITS SCHEME 2023-07-31 15:00
U.S. FDA Accepts Biologics License Application for GC Biopharma's GC5107B (Immune Globulin Intravenous (Human), 10% Liquid) 2023-07-31 13:20
Akeso Inc. Published 2023 Interim Results Positive Profit Alert 2023-07-31 12:33
NMPA and FDA Approved the First-in-Human Clinical Trial Applications to Evaluate LBL-034, An Anti-GPRC5D/CD3 Bispecific Antibody Developed by Leads Biolabs, in Relapsed/Refractory Multiple Myeloma 2023-07-31 12:09
Transcenta Anti-sclerostin Monoclonal Antibody TST002 (Blosozumab) Received Approval from China CDE to Initiate Phase II Clinical Trial in Patients with Reduced Bone Mineral Density 2023-07-31 08:10
Latest Updates of 7 Viva's Portfolio Companies 2023-07-28 19:31
HANQUYOU Marks 3rd Anniversary with Brilliant Achievements 2023-07-28 15:53
HANQUYOU Marks 3rd Anniversary with Brilliant Achievements 2023-07-28 15:27
Sirnaomics Appoints Dr. Francois Lebel as Senior Vice President for Preclinical and Clinical Development 2023-07-28 11:56
Empowering Regenerative Medicine: 3A-GTP Technology Ushers in a New Epoch 2023-07-28 10:00
Nutromics attracts world leaders in the emerging field of DNA-based sensing to join its Biosensor Advisory Board 2023-07-28 08:27
2023 Tsinghua Amgen Scholars Program Kicks Off 2023-07-27 21:00
HanAll Biopharma Reports Second Quarter 2023 Financial Results and Provides a Business Update 2023-07-27 19:00
Frost & Sullivan Awarded Duopharma Biotech with the 2022 Malaysian Company of the Year Award 2023-07-27 14:00
Acceptance Of Clinical Trial Application For The Recbio's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In China And Overseas Clinical Trial Progress 2023-07-27 10:57
GC Genome enables the prognosis prediction and targeted treatment in breast cancer patients 2023-07-27 08:53
1 90 91 92 93 94 452